Logo image
Molecular mechanisms of resistance and tolerance of Staphylococcus aureus to daptomycin
Journal article   Open access   Peer reviewed

Molecular mechanisms of resistance and tolerance of Staphylococcus aureus to daptomycin

Candice Lim, Geoffrey W. Coombs and Shakeel Mowlaboccus
International journal of antimicrobial agents, Vol.67(1), 107678
2025
PMID: 41297715
pdf
Published1.98 MBDownloadView
CC BY V4.0 Open Access

Abstract

daptomycin resistance daptomycin tolerance molecular mechanisms Staphylococcus aureus
Daptomycin is a cyclic lipopeptide antimicrobial used against gram-positive pathogens, including Staphylococcus aureus. Daptomycin relies on physiological calcium to anchor onto bacterial membranes and sequester lipid II, overproducing reactive oxygen species resulting in cell death. Although daptomycin is thought to be effective against approximately 80% of S. aureus, treatment failure can arise from resistant or tolerant cells. Daptomycin-resistant S. aureus typically acquires mutations in the multiple peptide resistance factor (MprF) to overproduce cationic lysyl-phosphatidylglycerol located on the outer membrane. The increase in positive cell surface charge inhibits daptomycin binding via electrostatic repulsion. Upon exposure to higher daptomycin concentrations, S. aureus may undergo further peptidoglycan modifications to attenuate daptomycin activity. These alterations can also be driven by the crosstalk in the signal transduction systems. Furthermore, the pathways in daptomycin resistance appear to overlap with tolerance which is understudied in S. aureus. In this review, we explore the current understanding of the complex interplay of molecular mechanisms involved in daptomycin resistance and tolerance in S. aureus.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

2 File views/ downloads
17 Record Views
Logo image